The Leadership Team at Verve Therapeutics is responsible for setting the strategic direction and overseeing the operational execution of the company's mission to develop groundbreaking genome-editing therapies for coronary artery disease. This diverse group of executives and scientists collaborates across disciplines such as research, clinical operations, regulatory affairs, and corporate strategy to ensure the successful advancement of innovative therapies from concept to clinical application, while fostering a culture of compliance, quality, and scientific excellence.
Andrew Ashe
President & COO
Barry Ticho
Co-Founder
Christopher J. Cheng
VP, Process Development & RNA ...
Ellen Rohde
VP, Pharmacology & Toxicology
J. Keith Joung
Co-Founder
Kallanthottathil G. ...
VP, CMC
Leslie Stolz
SVP, Regulatory Affairs
Scott Vafai
VP, Translational Medicine
Sekar Kathiresan
Co-Founder & CEO
Yasser El-Gamal
VP, Legal Affairs & Chief Inte...
View all